Demographic and health characteristics of 3,4-methylenedioxymethamphetamine users (MDMA, ecstasy)

被引:1
作者
Wieckiewicz, Gniewko [1 ]
Danel, Dariusz [2 ]
Piegza, Magdalena [1 ]
Gorczyca, Piotr [1 ]
Pudlo, Robert [1 ]
机构
[1] Slaski Uniwersytet Med Katowicach, Wydzial Nauk Med Zabrze, Katedra & Oddzial Klin Psychiat, Ul Pyskowicka 49, PL-42612 Katowice, Poland
[2] Polish Acad Sci, Inst Immunol & Terapii Doswiadczalnej Ludwika Hir, Poznan, Poland
关键词
HADS; MDMA; GHQ-28; SUBJECTIVE EXPERIENCES; CARE;
D O I
10.12740/PP/OnlineFirst/134317
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Aim. MDMA is one of the most commonly used drugs in the world. Clinical studies are currently being conducted around the world on the use of this substance in the treatment of PTSD and alcoholism. However, little demographic information is available on users who use the substance for non-medical purposes. The aim of the study was to determine basic demographic and health characteristics with validated tools. Method. The authors prepared an original questionnaire on the demography of MDMA users and combined it with the General Health Questionnaire-28 (GHQ-28) and the Hospital Anxiety and Depression Scale (HADS). The survey was sent to Polish MDMA users via the Internet. Results. 304 responses were received from people over 18 years of age. MDMA is widespread among young adults, in many different places of residence and regardless of gender. The users take MDMA in both pill and crystal form and very rarely test drugs bought from a dealer. Most users feel that MDMA has had a good impact on their lives. Conclusions. MDMA is rarely used as the only psychoactive substance. MDMA users rate their health higher than people using other psychoactive substances.
引用
收藏
页码:1109 / 1130
页数:22
相关论文
共 23 条
[1]  
[Anonymous], 2020, RAINBOW EUROPE
[2]  
[Anonymous], CLINICALTRIALS GOV
[3]   Patterns of Use, Acute Subjective Experiences, and Motivations for Using Synthetic Cathinones ("Bath Salts") in Recreational Users [J].
Ashrafioun, Lisham ;
Bonadio, Francis A. ;
Baik, Kyoung Deok ;
Bradbury, Stacey L. ;
Carhart, Victoria L. ;
Cross, Nicole A. ;
Davis, Alan K. ;
Feuille, Margaret ;
Harper, Anna R. ;
Lackey, Jennifer H. ;
Lang, Brent ;
Lauritsen, Kirstin J. ;
Leith, Jaclyn ;
Osborn, Lawrence A. ;
Rosenberg, Harold ;
Stock, Jacob ;
Zaturenskaya, Mariya .
JOURNAL OF PSYCHOACTIVE DRUGS, 2016, 48 (05) :336-343
[4]   Decision-making in chronic ecstasy users: a systematic review [J].
Betzler, Felix ;
Viohl, Leonard ;
Romanczuk-Seiferth, Nina .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2017, 45 (01) :34-44
[5]   Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users [J].
Brunt, Tibor M. ;
Koeter, Maarten W. ;
Niesink, Raymond J. M. ;
van den Brink, Wim .
PSYCHOPHARMACOLOGY, 2012, 220 (04) :751-762
[6]   Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline [J].
Feduccia, Allison A. ;
Jerome, Lisa ;
Yazar-Klosinski, Berra ;
Emerson, Amy ;
Mithoefer, Michael C. ;
Doblin, Rick .
FRONTIERS IN PSYCHIATRY, 2019, 10
[7]  
Frydecka D, 2010, PSYCHIATR POL, V44, P341
[8]   Associations with drug use and sexualised drug use among women who have sex with women (WSW) in the UK: Findings from the LGBT Sex and Lifestyles Survey [J].
Hibbert, Matthew Peter ;
Porcellato, Lorna A. ;
Brett, Caroline E. ;
Hope, Vivian D. .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2019, 74 :292-298
[9]   Additive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Compassionate Imagery on Self-Compassion in Recreational Users of Ecstasy [J].
Kamboj, Sunjeev K. ;
Wallden, Ylva S. E. ;
Falconer, Caroline J. ;
Alotaibi, Majdah Raji ;
Blagbrough, Ian S. ;
Husbands, Stephen M. ;
Freeman, Tom P. .
MINDFULNESS, 2018, 9 (04) :1134-1145
[10]  
Makowska Z., 2001, OCENA ZDROWIA PSYCHI